1. Home
  2. VERU vs PHD Comparison

VERU vs PHD Comparison

Compare VERU & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • PHD
  • Stock Information
  • Founded
  • VERU 1971
  • PHD 2004
  • Country
  • VERU United States
  • PHD United States
  • Employees
  • VERU N/A
  • PHD N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • PHD Investment Managers
  • Sector
  • VERU Health Care
  • PHD Finance
  • Exchange
  • VERU Nasdaq
  • PHD Nasdaq
  • Market Cap
  • VERU 107.2M
  • PHD 121.9M
  • IPO Year
  • VERU 1990
  • PHD N/A
  • Fundamental
  • Price
  • VERU $0.74
  • PHD $9.75
  • Analyst Decision
  • VERU Strong Buy
  • PHD
  • Analyst Count
  • VERU 4
  • PHD 0
  • Target Price
  • VERU $4.00
  • PHD N/A
  • AVG Volume (30 Days)
  • VERU 1.6M
  • PHD 67.7K
  • Earning Date
  • VERU 02-06-2025
  • PHD 01-01-0001
  • Dividend Yield
  • VERU N/A
  • PHD 11.43%
  • EPS Growth
  • VERU N/A
  • PHD N/A
  • EPS
  • VERU N/A
  • PHD 1.27
  • Revenue
  • VERU $16,886,419.00
  • PHD N/A
  • Revenue This Year
  • VERU N/A
  • PHD N/A
  • Revenue Next Year
  • VERU N/A
  • PHD N/A
  • P/E Ratio
  • VERU N/A
  • PHD $7.60
  • Revenue Growth
  • VERU 3.62
  • PHD N/A
  • 52 Week Low
  • VERU $0.36
  • PHD $8.30
  • 52 Week High
  • VERU $1.92
  • PHD $9.81
  • Technical
  • Relative Strength Index (RSI)
  • VERU 56.66
  • PHD 47.65
  • Support Level
  • VERU $0.63
  • PHD $9.66
  • Resistance Level
  • VERU $0.88
  • PHD $9.79
  • Average True Range (ATR)
  • VERU 0.09
  • PHD 0.08
  • MACD
  • VERU 0.00
  • PHD -0.00
  • Stochastic Oscillator
  • VERU 49.11
  • PHD 53.45

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

About PHD Pioneer Floating Rate Fund Inc.

Pioneer Floating Rate Trust is a diversified, closed-end fund. Its investment objective is to provide a high level of current income and seek the preservation of capital by investing predominantly in floating-rate loans.

Share on Social Networks: